Kintsugi is an unclaimed profile.
If you work at Kintsugi, sign up or log in to claim the profile today.
Kintsugi

Kintsugi

Kintsugi develops AI-driven voice biomarker technology to detect signs of depression and anxiety from brief, free-form speech samples. Their primary offering, Kintsugi Voice, is an API-first platform that integrates with call centers, telehealth systems, and remote patient monitoring applications to identify mental health challenges in real time.

Overview

Product Overview

Security and Compliance Certifications: SOC 2 Type 2, HIPAA, GDPR
Kintsugi develops AI-driven voice biomarker technology to detect signs of depression and anxiety from brief, free-form speech samples. Their primary offering, Kintsugi Voice, is an API-first platform that integrates with call centers, telehealth systems, and remote patient monitoring applications to identify mental health challenges in real time. This technology analyzes vocal features without relying on the content of speech, enabling language-agnostic assessments.

Customers Served

Ambulatory Practice
Hospital / Health System

Categories

Company Info

HQ Location
Berkeley, California
Founded
2019
Headcount
11-50
Total Funding
$30.9M
Latest Round
Series A
Latest Round
02/28/2022

Company Socials

LinkedIn
X
Crunchbase
YouTube
Vimeo
GitHug

Demos

Similar Products

Company Info
Founded: 2010
Headcount: 51-200
Customers
Verified Customers: 3
Customers Served: Ambulatory Practice, Hospital / Health System
Product Overview
Security and Compliance Certifications: HIPAA
LumineticsCore by Digital Diagnostics is an AI diagnostic system that autonomously detects diabetic retinopathy, including macular edema, at the point-of-care using fundus images captured by a trained operator. It provides rapid results without needing specialist review, which facilitates immediate care decisions and referrals if disease is detected. The system is designed for healthcare providers, eye care professionals, payors, and patients, enhancing access to diagnostic evaluations for people with diabetes.
Paige logo
Paige

Paige

Company Info
Founded: 2018
Headcount: 51-200
Customers
Verified Customers: 9
Customers Served: Hospital / Health System, Ambulatory Practice, Life Sciences
Product Overview
Security and Compliance Certifications: ISO 13485, FDA Approval
Paige offers an AI-powered digital pathology platform designed to assist pathologists in diagnosing cancer and other diseases from pathology slides. The platform includes tools for detecting, quantifying, and visualizing tumor areas, providing decision support and streamlining workflows. Paige's AI models are trained on large datasets of pathology images and integrate with existing lab systems to enhance diagnostic accuracy and efficiency in clinical settings.
Syntrillo logo
Syntrillo

Syntrillo

Company Info
Founded: 2020
Headcount: 1-10
Customers
Customers Served: Ambulatory Practice, Hospital / Health System
Product Overview
Security and Compliance Certifications: HIPAA
Syntrillo is developing an AI-enabled telehealth platform aimed at preventing strokes by integrating data from wearable devices and clinical records to monitor and manage patients' stroke risk. The platform features an automated disease monitoring system that models patient risk and behavior, generates personalized prevention plans, and includes an AI virtual assistant providing 24/7 support to patients and providers. Additionally, Syntrillo offers access to a remote care team comprising neurologists, nurse practitioners, and rehabilitation specialists to ensure comprehensive care.